Salta al contenuto principale
Ricerc@Sapienza
Toggle navigation
Home
Login
Home
Persone
miriam.lichtner@uniroma1.it
Miriam Lichtner
Professore Ordinario
Struttura:
DIPARTIMENTO DI NEUROSCIENZE, SALUTE MENTALE E ORGANI DI SENSO
E-mail:
miriam.lichtner@uniroma1.it
Pagina istituzionale corsi di laurea
Curriculum Sapienza
Pubblicazioni
Titolo
Pubblicato in
Anno
Prevalence of single and multiple natural NS3, NS5A and NS5B resistance-associated substitutions in hepatitis C Virus Genotypes 1-4 in Italy
SCIENTIFIC REPORTS
2018
Frequent NS5A and multiclass resistance in almost all HCV genotypes at DAA failures: What are the chances for second-line regimens?
JOURNAL OF HEPATOLOGY
2018
Soluble CD163 in CMV-Infected and CMV-Uninfected subjects on virologically suppressive antiretroviral therapy in the ICONA Cohort
JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
2017
Immunological diagnosis as an adjunctive tool for an early diagnosis of tuberculous meningitis of an immune competent child in a low tuberculosis endemic country: A case report
BMC RESEARCH NOTES
2017
Multiclass HCV resistance to direct-acting antiviral failure in real-life patients advocates for tailored second-line therapies
LIVER INTERNATIONAL
2017
Efficacy and tolerability of switching to a dual therapy with darunavir/ritonavir plus raltegravir in HIV-infected patients with HIV-1 RNA ≤50 cp/mL
INFECTION
2017
Changes in inflammatory biomarkers in HCV-infected patients undergoing direct acting antiviral-containing regimens with or without interferon
PLOS ONE
2017
Active HCV Replication but Not HCV or CMV Seropositive Status is associated with Incident and Prevalent Type 2 Diabetes in Persons living with HIV
JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
2017
Comparative evaluation of subtyping tools for surveillance of newly emerging HIV-1 strains
JOURNAL OF CLINICAL MICROBIOLOGY
2017
Active HCV infection is associated with increased circulating levels of interferon-gamma (IFN-γ)-inducible protein-10 (IP-10), soluble CD163 and inflammatory monocytes regardless of liver fibrosis and HIV coinfection
CLINICS AND RESEARCH IN HEPATOLOGY AND GASTROENTEROLOGY
2017
Dynamics and phylogenetic relationships of HIV-1 transmitted drug resistance according to subtype in Italy over the years 2000-14
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
2017
Hepatitis Delta Antigen (HDAg) is characterized by an extensive degree of genetic variability that correlates with elevated levels of serum HDV-RNA
Journal of hepatologyJOURNAL OF HEPATOLOGY
2017
The circulation of specific vaccine-escape HBsAg mutations in HBV genotype D infected patients correlates with high viremia and affects HBsAg detection and quantification
JOURNAL OF HEPATOLOGY
2017
In HBeAg-negative chronic HBV infection, HBsAg levels profoundly vary among different HBV-genotypes and can be influenced by the degree of HBsAg variability: can quantitative HBsAg truly reflect intra-hepatic HBV reservoir?
JOURNAL OF HEPATOLOGY
2017
Novelties in Evaluation and Monitoring of Human Immunodeficiency Virus-1 Infection: Is Standard Virological Suppression Enough for Measuring Antiretroviral Treatment Success?
AIDS REVIEWS
2017
Access and response to direct antiviral agents (DAA) in HIV-HCV co-infected patients in Italy: data from the Icona cohort
PLOS ONE
2017
Awareness, discussion and non-prescribed use of HIV pre-exposure prophylaxis among persons living with HIV/AIDS in Italy: A Nationwide, cross-sectional study among patients on antiretrovirals and their treating HIV physicians
BMC INFECTIOUS DISEASES
2017
Treatment of latent tuberculosis infection induces changes in multifunctional Mycobacterium tuberculosis-specific CD4(+) T cells
MEDICAL MICROBIOLOGY AND IMMUNOLOGY
2016
Blood myeloid dendritic cells and slandc in antiretroviral therapy-suppressed hiv-infected patients
CURRENT HIV RESEARCH
2016
Rapid decline of fasting glucose in HCV diabetic patients treated with direct-acting antiviral agents
CLINICAL MICROBIOLOGY AND INFECTION
2016
« prima
< precedente
1
2
3
4
5
6
7
seguente ›
ultima »
Progetti di Ricerca
Marcatori di risposta e modificazioni del pattern infiammatorio in una corte di pazienti con polmonite da SARS-Cov2 sottoposti al trattamento con farmaci immunomodulanti
Ruolo dell'immunità innata nell'infezione da SARS-COV2 in una corte di pazienti con polmonite da COVID: biomarkers e correlati clinici
Risposta immune innata e immuno-attivazione T in pazienti coinfetti HIV/HCV sottoposti a farmaci ad azione diretta anti HCV (DAA) Innate immunity and immune activation in HIV/HCV coinfected subjects undergoing DAA
- Impatto dell'eradicazione di HCV nel controllo dell'immunoattivazione residua in pazienti HIV/HCV coinfetti - HCV eradication in HIV/HCV co-infected patients: impact on residual immune-activation.
Immunità mucosale nella donna HIV positiva in terapia antiretrovirale efficace: biomarcatori e correlati clinici Mucosal Immunity in HIV-1 infected women undergoing effective antiretroviral therapy: biomarkers and clinical determinants
© Università degli Studi di Roma "La Sapienza" - Piazzale Aldo Moro 5, 00185 Roma